June 25-26, 2020

3rd Annual MarketsandMarkets Next-Gen Immuno-Oncology Congress - Virtual Event (Time Zone - ET)

45+
Speakers
200+
Attendees
4
Networking Hours
5+
Sessions

Due to growing concerns about COVID-19, the 3rd Annual MarketsandMarkets Next Gen IO Congress is going fully virtual this year. We are disappointed that we are not able to come together in person in June for this event, but we are so thrilled to see you on an online platform. We are working together to create a virtual conference that will be beneficial and engaging for speakers, attendees and sponsors/exhibitors.

See the Post Show report of our 2nd Annual here

Please write to [email protected] for questions regarding speaking, attending and sponsoring. We will keep you posted with the event flow soon. Keep checking our website.

WHAT TO EXPECT
Key Highlights
  • Immune Checkpoint Inhibitors and Combinations
  • Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
  • Monoclonal Antibody & Cellular Therapy
  • Neoantigens in personalized Cancer Immunotherapy
  • Biomarkers and Cancer Vaccines
  • Developments in CAR-T Cellular Therapy
  • Oncolytic Viral Therapy & Personalized Medicine
  • Engineering Cellular Therapies Beyond Traditional Tumor Antigens
  • Combination Therapies in I/O
Why attend Virtual?
  • Exclusive Virtual event to learn about antibodies, cellular therapy and immune-checkpoint research under one roof
  • Find out new case studies of immune-oncology projects in development
  • Contribute to interactive Q&A sessions with your peers to deliberate key topics most relevant to you
  • Explore the latest platforms and technologies on the market for development
  • Discuss the best tool for your research in immune-oncology
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Board Member
MarketsandMarkets

Shailendra Singh (Shelly)

Board Member
MarketsandMarkets
Roy Baynes

Roy Baynes

Senior Vice President
Merck

Roy Baynes

Senior Vice President
Merck
Mithun Khattar

Mithun Khattar

Immuno-Oncology Lead
Takeda Oncology

Mithun Khattar

Immuno-Oncology Lead
Takeda Oncology
Stefan Gluck

Stefan Gluck

Vice President, Global Head Franchise Oncology
Regeneron

Stefan Gluck

Vice President, Global Head Franchise Oncology
Regeneron
Nuzhat Pathan

Nuzhat Pathan

Director, Early Development, Translational and Immuno-Oncology
Pfizer

Nuzhat Pathan

Director, Early Development, Translational and Immuno-Oncology
Pfizer
Philip Arlen

Philip Arlen

Chief Scientific Officer, Senior Vice President
Diverse Biotech

Philip Arlen

Chief Scientific Officer, Senior Vice President
Diverse Biotech
Nathaniel Wang

Nathaniel Wang

Oncology Vaccines Project Leader
Janssen, Pharmaceutical Companies of Johnson and Johnson

Nathaniel Wang

Oncology Vaccines Project Leader
Janssen, Pharmaceutical Companies of Johnson and Johnson
Shailesh Maingi

Shailesh Maingi

Founder and CEO
Kineticos Life Sciences

Shailesh Maingi

Founder and CEO
Kineticos Life Sciences
SPONSORS
Gold
example-image

BIOCYTOGEN

example-image

Applied BioMath

example-image

QIAGEN

Silver
example-image

PhenoSwitch Bioscience

Sponsors & Exhibitors
example-image

PromoCell

example-image

TransCure bioServices

example-image

BerGenBio

example-image

Imaging Endpoints

example-image

Q2 Solutions

example-image

CellGenix

example-image

Thermo Fisher Scientific

example-image

PHC Group

example-image

PHC Group

example-image

PHC Group

example-image

Proteome Sciences

example-image

Eppendorf

example-image

Cook Regentec

example-image

BioIVT

example-image

NeoGenomics

PAST EVENT GALLERY